Wies: “The trend for 2024? Focus on menopause”

Gynaecologist Dorenda van Dijken is set to commence a major menopause study in January 2024, working alongside a team of scientists from various hospitals, (government) organisations, and patient associations. One of the aims is to explore how menopause can be better integrated into society.

Menopause and work is another key area of research. At present, it’s unclear what the most effective solutions are. Hormone therapy is not a one-size-fits-all answer. Perhaps other adjustments in the workplace are needed. Starting the working day later, for instance, or initiating conversations with women at an earlier stage; these are all possibilities being considered.

The study will span six to eight years. I think this is fantastic news. My generation is actually the first to participate so actively in the workforce. For future generations, we must ensure they are better prepared.

New forms of hormone therapy are also emerging. For example, the NK3R antagonist is an intriguing newcomer. It’s a non-hormonal treatment that has proven effective against hot flushes and night sweats. Unfortunately, it has not yet been tested on women with breast cancer, for whom a non-hormonal option could represent a significant breakthrough. Additionally, a new pill combining natural oestrogen and natural progesterone is being introduced. Such a combination has not been available until now.

If you look at global trend reports for 2024, menopause is frequently highlighted. The prediction is that more products and services will be developed to help women navigate menopause successfully. Personalised support is also expected to gain popularity. In short: menopause is becoming a hot topic! That calls for a toast (one glass of champagne should be fine).

Wies Verbeek (58) is a journalist, founder of the website BLOW.nl, and author of the book ’n Beetje Leuk Ouder Worden, 101 verrassende en bewezen tips (A Bit of Fun Ageing, 101 Surprising and Proven Tips). And she’s right in the middle of menopause.